O
ISSUER//CIK 0001850838
Omega Therapeutics, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 8-K157.8 KBOmega Therapeutics, Inc.Feb 24, 4:48 PM ET·0001193125-25-033500
- 8-K161.6 KBOmega Therapeutics, Inc.Feb 14, 4:59 PM ET·0001193125-25-027349
- 8-K169.7 KBOmega Therapeutics, Inc.Feb 3, 5:05 PM ET·0001193125-25-019359
- 8-K149.2 KBOmega Therapeutics, Inc.Jan 28, 4:28 PM ET·0001193125-25-014403
- 8-K153.0 KBOmega Therapeutics, Inc.Jan 17, 5:00 PM ET·0001193125-25-008477
- 8-K146.5 KBOmega Therapeutics, Inc.Jan 10, 4:47 PM ET·0001193125-25-004507
- 8-K154.4 KBOmega Therapeutics, Inc.Dec 31, 5:30 PM ET·0001193125-24-287201
- 8-K148.5 KBOmega Therapeutics, Inc.Dec 6, 5:00 PM ET·0001193125-24-272532
- 8-K7.9 MBOmega Therapeutics, Inc.Nov 14, 4:16 PM ET·0001193125-24-258595
- 10-Q9.9 MBOmega Therapeutics, Inc.Nov 14, 4:00 PM ET·0000950170-24-127008
Insiders
10- AFEYAN NOUBARDirector, 10% Owner
- Artal Group S.A.10% Owner
- Artal International S.C.A.10% Owner
- BERRY DAVID ADirector
- BESHAR LUKE MDirector
- Boehm Rainer J.Director
- Certel KaanChief Business Officer
- Chan Barbara YChief Accounting Officer
- Flagship Pioneering Fund VII, L.P.10% Owner
- Flagship Pioneering Inc.10% Owner
Tickers
No tickers on record
Addresses
business
140 FIRST STREET, SUITE 501
CAMBRIDGE, MA, 02141
mailing
140 FIRST STREET, SUITE 501
CAMBRIDGE, MA, 02141